Bisphosphonate-related Osteonecrosis of the Jaw
📧 Sign up to get email alerts when something new happens for Bisphosphonate-related Osteonecrosis of the Jaw.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) [Phase 3]
Phase 3 clinical trial update for Pentoxifylline and Tocopherol (PENTO) in treating medication-related osteonecrosis of the jaw.
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) [Phase 3]
Phase 3 trial update noting ongoing enrollment by invitation for Pentoxifylline and Tocopherol (PENTO) in medication-related osteonecrosis o…
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Use of Topical Phenytoin in Bisphosphonate-related Osteonecrosis of the Mandible [NA]
The trial evaluating topical phenytoin for bisphosphonate-related osteonecrosis of the jaw has completed. It was sponsored by Shiraz Univers…
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
A clinical trial update examining genetic risk factors for osteonecrosis of the jaw in patients with metastatic cancer, including those expo…
-
CLINICAL_TRIALS research · 2014-08-18Clinical Trial Update: Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay [NA]
This document provides an update on a clinical trial evaluating the performance of Micromedic's BRONJ risk assessment in an in vitro diagnos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.